People

Cohero Health has announced 5 new hires "to scale for growth and drive commercial sales of its BreatheSmart platform." In 2016, Cohero and H&T Presspart announced that they had partnered on development of an electronic inhaler called the eMDI. The new hires are: Amber Thompson, Chief Client Officer; Sergio Carbone, Chief Information and Technology Officer; Yury … [Read more...] about Cohero Health announces new management hires

Intranasal drug developer Impel NeuroPharma has hired Lynn C. Gold as Senior VP of Regulatory Affairs, the company said. Gold was most recently VP of Scientific and Regulatory Affairs at Camargo Pharmaceutical Services and had previously served as VP of Research and Process Development at Sonus Pharmaceuticals. In 2017, Impel announced that it had signed service … [Read more...] about Impel NeuroPharma names Lynn Gold Senior VP of Regulatory Affairs

Former Mylan Senior Director of Inhalation Biopharmaceutics Per Bäckman has joined Emmace Consulting as Senior Inhalation Consultant, the company has announced. Bäckman also previously held various positions at AstraZeneca, including as Principal Scientist in Inhalation Biopharmaceutics, and at Novo Nordisk. Emmace Consulting CEO Mårten Svensson said, "Per Bäckman … [Read more...] about Per Bäckman joins Emmace Consulting

Galecto Biotech, which is developing an inhaled galectin-3 inhibitor for the treatment of idiopathic pulmonary fibrosis (IPF), has hired former GSK VP and Head of the Fibrosis & Lung Injury Discovery Performance Unit Richard Marshall as its Chief Medical Officer, the company said. Marshall held a number of positions in respiratory drug development at GSK over 15 … [Read more...] about Galecto Biotech names Richard Marshall as Chief Medical Officer

Liquidia Technologies has named Jeri Thomas as its new Senior VP Commercial, responsible initially for commercial plans for the company's LIQ861 treprostinil DPI, which is currently in Phase 3 development for the treatment of pulmonary arterial hypertension (PAH). According to Liquidia, Thomas was most recently Senior VP, Strategic Group Planning at healthcare … [Read more...] about Liquidia Technologies appoints Jeri Thomas Senior VP, Commercial

TFF Pharmaceuticals, which recently announced that it had raised $14 million for the development of DPI formulations, has named former Arno Therapeutics CEO Glenn Mattes as its new Chief Executive Officer. Mattes's career includes management and board positions with a number of pharmaceutical companies, including Johnson & Johnson subsidiaries Tibotec Therapeutics and … [Read more...] about TFF Pharmaceuticals appoints Glen Mattes as CEO

Swedish instrument company Inhalation Sciences has announced the appointment of Lena Heffler as its new CEO effective May 7, 2018. She will succeed Fredrik Sjövall, who is expected to become Chairman of the Board. Heffler said, "Inhalation Sciences is a company with a unique and very exciting technology platform that has the potential to make a huge difference to … [Read more...] about Inhalation Sciences names Lena Heffler as CEO

Pneuma Respiratory, which introduced a digital soft mist inhaler in November 2017, has announced the appointment of former Boehringer Ingelheim VP of Respiratory Products Steven Kesten as its new President and Chief Medical Officer. Since leaving Boehringer Ingelheim in 2010, Kesten has held VP and Chief Medical Officer positions at Uptake Medical and Cytori … [Read more...] about Pneuma Respiratory appoints Steven Kesten as President and Chief Medical Officer